ASH1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.366000E-01
Normal-vs-Stage2
6.369600E-01
Normal-vs-Stage3
4.776000E-02
Normal-vs-Stage4
4.519800E-01
Stage1-vs-Stage2
2.118600E-01
Stage1-vs-Stage3
2.001800E-02
Stage1-vs-Stage4
4.451400E-01
Stage2-vs-Stage3
1.544430E-03
Stage2-vs-Stage4
2.766000E-01
Stage3-vs-Stage4
1.028820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.139200E-01
Normal-vs-AfricanAmerican
6.819800E-01
Normal-vs-Asian
5.679200E-01
Caucasian-vs-AfricanAmerican
1.749550E-01
Caucasian-vs-Asian
7.743600E-01
AfricanAmerican-vs-Asian
2.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.998200E-01
Normal-vs-Female
6.191800E-01
Male-vs-Female
6.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.311000E-01
Normal-vs-Age(41-60Yrs)
9.776800E-01
Normal-vs-Age(61-80Yrs)
5.529800E-01
Normal-vs-Age(81-100Yrs)
2.311000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.925200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.701000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.552600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.768000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.692300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.927000E-01
Normal-vs-Daily Drinker
1.627590E-01
Normal-vs-Weekly Drinker
5.104800E-01
Normal-vs-Occasional Drinker
9.699600E-01
Normal-vs-Social Drinker
9.083400E-01
Non Drinker-vs-Daily Drinker
2.622800E-01
Non Drinker-vs-Weekly Drinker
8.905000E-01
Non Drinker-vs-Occasional Drinker
3.608500E-02
Non Drinker-vs-Social Drinker
2.432600E-01
Daily Drinker-vs-Weekly Drinker
3.693400E-01
Daily Drinker-vs-Occasional Drinker
7.044600E-03
Daily Drinker-vs-Social Drinker
5.542100E-02
Weekly Drinker-vs-Occasional Drinker
1.764960E-01
Weekly Drinker-vs-Social Drinker
3.928400E-01
Occasional Drinker-vs-Social Drinker
7.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.131600E-02
Normal-vs-Grade 2
2.388000E-02
Normal-vs-Grade 3
3.546200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.371000E-01
Grade 1-vs-Grade 3
2.243800E-01
Grade 1-vs-Grade 4
6.131600E-02
Grade 2-vs-Grade 3
4.193200E-01
Grade 2-vs-Grade 4
2.388000E-02
Grade 3-vs-Grade 4
3.546200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.844200E-01
Normal-vs-NonDiabetic
4.882200E-01
Diabetic-vs-NonDiabetic
7.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.955200E-01
Normal-vs-NoPancreatitis
5.361600E-01
Pancreatitis-vs-NoPancreatitis
7.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.470800E-01
Normal-vs-N1
6.341000E-01
N0-vs-N1
7.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.966400E-01
Normal-vs-TP53-NonMutant
8.557200E-01
TP53-Mutant-vs-TP53-NonMutant
5.202000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
